As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Dss, Inc. The largest reported stake is Heng Fai Ambrose Chan's, at 86.3%. 4 filings are on record since August 22, 2025 (Schedule 13D/A, September 8, 2026).
Sell to companies like Dss, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Heng Fai Ambrose Chan · Sole voting: 26,311,715 · Shared voting: 0 · Sole dispositive: 26,311,715 · Shared dispositive: 0 · SCHEDULE 13D/A, 2026-09-08
- · Holder: Heng Fai Ambrose Chan · Percent: 86.8% · SCHEDULE 13D/A
- · Holder: Heng Fai Ambrose Chan · Percent: 68.2% · SCHEDULE 13D/A
- · Holder: Heng Fai Ambrose Chan · Percent: 69.6% · SCHEDULE 13D/A
Dss, Inc. has 4 Schedule 13D or 13G filings on record since 2025-08-22. 1 holder's latest filing reports 5% or more of common stock, par value $0.02 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 86.3% | 26,311,715 | SCHEDULE 13D/A, 2026-09-08 | 2026-09-03 |
Holding shares or following this stake? See who's behind Dss, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Dss, Inc. and the records around it.
Dss, Inc. elsewhere on the record
Companies that share a holder
- Heng Fai Ambrose Chan also filed stake reports on 3 other companies: HWH International Inc. (Aug 2026), SHARING SERVICES GLOBAL Corp (Mar 2026), Alset Inc. (Sep 2025)
Watch Dss, Inc.
Get an email when Dss, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Dss, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Dss, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Dss, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Heng Fai Ambrose Chan | 26,311,715 | 0 | 26,311,715 | 0 | SCHEDULE 13D/A, 2026-09-08 |
| Alset Inc. | 24,407,472 | 0 | 24,407,472 | 0 | SCHEDULE 13D/A, 2026-09-08 |
| Global Biomedical Pte. Ltd. | 311,634 | 0 | 311,634 | 0 | SCHEDULE 13D/A, 2026-09-08 |
| Alset International Limited | 21,244,809 | 0 | 21,244,809 | 0 | SCHEDULE 13D/A, 2026-09-08 |
The latest filing identifies Dss, Inc. by CUSIP 26253C201 and gives its principal executive office as 275 Wiregrass Pkwy, West Henrietta, NY 14586 (SCHEDULE 13D/A, 2026-09-08).
Source of funds (Item 3)
On September 3, 2026 Chan Heng Fai sold 21,852 shares of the Issuer's common stock at a sale price of $0.82 per share.Heng Fai Ambrose Chan, SCHEDULE 13D/A, 2026-09-08
Purpose of Transaction (Item 4)
Heng Fai Ambrose Chan
On September 3, 2026 Chan Heng Fai sold 21,852 shares of the Issuer's common stock at a sale price of $0.82 per share.Item 4 of the SCHEDULE 13D/A filed 2026-09-08
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-22 | Heng Fai Ambrose Chan | 69.6% | SCHEDULE 13D/A |
| 2025-09-02 | Heng Fai Ambrose Chan | 68.2% | SCHEDULE 13D/A |
| 2026-07-09 | Heng Fai Ambrose Chan | 86.8% | SCHEDULE 13D/A |
| 2026-09-08 | Heng Fai Ambrose Chan | 86.3% | SCHEDULE 13D/A |
Questions about who owns Dss, Inc.
Who owns Dss, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Dss, Inc.: Heng Fai Ambrose Chan (86.3%, Schedule 13D/A, filed 2026-09-08).
When did Heng Fai Ambrose Chan buy into Dss, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Heng Fai Ambrose Chan on this page is the Schedule 13D/A, filed 2025-08-22, reporting 69.6%; its latest, Schedule 13D/A filed 2026-09-08, reports 86.3%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Dss, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.